Cian Healthcare Fair Value
Fair Value Analysis Export
P/B Based Valuation
Asset-Based Valuation
CHCL Fair Value Analysis — Data Sources & Coverage
Cian Healthcare financial data sources, valuation methods applied and sector benchmarks used. Explore Cian Healthcare intrinsic price to estimate fundamental worth using multiple valuation models.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
CHCL vs Healthcare Sector Peers — P/E, P/B & Market Cap
Cian Healthcare P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Emcure Pharmaceuticals | EMCURE | 35.85 | 7.38 | ₹37,156 |
| Syngene International | SYNGENE | 68.69 | 3.13 | ₹15,000 |
| Divis Laboratories | DIVISLAB | 87.22 | 15.22 | ₹253,522 |
| Aurobindo Pharma | AUROPHARMA | 25.97 | 2.54 | ₹96,479 |
| Sat Kartar Life | SATKARTAR | 16.56 | 4.14 | ₹307 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.